Complement Kidney Disease (23 results)

Hardcover/Pappeinband. Condition: Sehr gut. 252 p. Very good. Shrink wrapped. / Sehr guter Zustand. In Folie verschweißt. Sprache: Englisch Gewicht in Gramm: 753.

Condition: New. pp. 260 Illus.

Condition: New. pp. 260.

Condition: New. pp. 260.

Taschenbuch. Condition: Neu. Complement regulatory proteins and chronic kidney disease | Expression levels of complement regulatory proteins on peripheral blood cells of patients with chronic kidney disease | Alshaymaa Alhabibi Et Al | Taschenbuch | Englisch | 2021 | LAP LAMBERT Academic Publishing | EAN 9786200215543 | Verantwortliche Person für die EU: preigu GmbH & Co. KG, Lengericher Landstr. 19, 49078 Osnabrück, mail[at]preigu[dot]de | Anbieter: preigu.

Condition: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.

Condition: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service.

Hardcover. Condition: New. In shrink wrap. Looks like an interesting title!

Hardcover. Condition: New. In shrink wrap. Looks like an interesting title!

Condition: New. In.

Condition: New. It is evident that a defective or deregulated complement system results in kidney diseases. An important role of complement effector and regulatory proteins in pathological settings of the kidney has been demonstrated. This book discusses Molecular biology, clinics and therapy. Editor(s): Zipfel, Peter F. Series: Progress in Inflammation Research. Num Pages: 252 pages, biography. BIC Classification: MFG; MJCM; MJR; MMFM; PSF. Category: (P) Professional & Vocational. Dimension: 235 x 155 x 16. Weight in Grams: 603. . 2005. 2006th Edition. hardcover. . . . .

Buch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - It is evident that a defective or deregulated complement system results in kidney diseases. An important role of complement effector and regulatory proteins in pathological settings of the kidney has been demonstrated. A large panel of distinct human kidney diseases is caused by defective complement control. Genetic analyses have identified mutations in complement regulators that are associated with these diseases. Mutations have been identified in the fluid phase alternative pathway regulator Factor H and the membrane regulator Membrane Cofactor Protein MCP (CD46). The functional characterization of the mutant proteins allows to define the pathophysiological events on a molecular level. These new concepts and data on disease mechanisms allowed establishing new diagnostic and promising therapeutic approaches for several human kidney diseases. Molecular biology, clinics and therapy are discussed in this volume.

Hardcover. Condition: Brand New. 1st edition. 236 pages. 9.00x6.50x0.75 inches. In Stock.

Condition: New. It is evident that a defective or deregulated complement system results in kidney diseases. An important role of complement effector and regulatory proteins in pathological settings of the kidney has been demonstrated. This book discusses Molecular biology, clinics and therapy. Editor(s): Zipfel, Peter F. Series: Progress in Inflammation Research. Num Pages: 252 pages, biography. BIC Classification: MFG; MJCM; MJR; MMFM; PSF. Category: (P) Professional & Vocational. Dimension: 235 x 155 x 16. Weight in Grams: 603. . 2005. 2006th Edition. hardcover. . . . . Books ship from the US and Ireland.

Hardcover. Condition: Like New. LIKE NEW. SHIPS FROM MULTIPLE LOCATIONS. book.

Taschenbuch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -We examined the expression of the three complement regulatory proteins on erythrocytes, neutrophils, lymphocytes and monocytes from pediatric patients and controls. The proportion of cells expressing the three complement regulatory proteins varied between the cell types we examined, as did the levels of expression of the proteins.Similar to the findings from pediatric patients, there were lower proportion of erythrocytes expressing CD35, CD55 and CD59 in adult patients than in adult controls. In addition, there were lower proportion of CD59-positive neutrophils and CD35-, CD59-positive lymphocytes, and CD59-positive monocytes in adult patients than in adult controls. When looking at protein levels, we observed that the MFI of CD35-positive erythrocytes was significantly higher in adult patients than in the adult control, while CD59-positive neutrophils and monocytes was significantly lower in adult patients than in the adult controls.The findings so far showed that there was, at least to some extent, a correlation between the expression of the complement regulatory proteins and the presence or absence of the disease. 56 pp. Englisch.

Condition: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: Alhabibi et al AlshaymaaI am Dr. Alshaymaa Mohamed Alhabibi, Lecturer of Clinical Pathology Department at the Faculty of Medicine/ Al-Azhar University for Girls. I have been a lecturer for 4 years and I participate in the academic te.

Taschenbuch. Condition: Neu. This item is printed on demand - Print on Demand Titel. Neuware -We examined the expression of the three complement regulatory proteins on erythrocytes, neutrophils, lymphocytes and monocytes from pediatric patients and controls. The proportion of cells expressing the three complement regulatory proteins varied between the cell types we examined, as did the levels of expression of the proteins.Similar to the findings from pediatric patients, there were lower proportion of erythrocytes expressing CD35, CD55 and CD59 in adult patients than in adult controls. In addition, there were lower proportion of CD59-positive neutrophils and CD35-, CD59-positive lymphocytes, and CD59-positive monocytes in adult patients than in adult controls. When looking at protein levels, we observed that the MFI of CD35-positive erythrocytes was significantly higher in adult patients than in the adult control, while CD59-positive neutrophils and monocytes was significantly lower in adult patients than in the adult controls.The findings so far showed that there was, at least to some extent, a correlation between the expression of the complement regulatory proteins and the presence or absence of the disease.VDM Verlag, Dudweiler Landstraße 99, 66123 Saarbrücken 56 pp. Englisch.

Taschenbuch. Condition: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - We examined the expression of the three complement regulatory proteins on erythrocytes, neutrophils, lymphocytes and monocytes from pediatric patients and controls. The proportion of cells expressing the three complement regulatory proteins varied between the cell types we examined, as did the levels of expression of the proteins.Similar to the findings from pediatric patients, there were lower proportion of erythrocytes expressing CD35, CD55 and CD59 in adult patients than in adult controls. In addition, there were lower proportion of CD59-positive neutrophils and CD35-, CD59-positive lymphocytes, and CD59-positive monocytes in adult patients than in adult controls. When looking at protein levels, we observed that the MFI of CD35-positive erythrocytes was significantly higher in adult patients than in the adult control, while CD59-positive neutrophils and monocytes was significantly lower in adult patients than in the adult controls.The findings so far showed that there was, at least to some extent, a correlation between the expression of the complement regulatory proteins and the presence or absence of the disease.

Buch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -It is evident that a defective or deregulated complement system results in kidney diseases. An important role of complement effector and regulatory proteins in pathological settings of the kidney has been demonstrated. A large panel of distinct human kidney diseases is caused by defective complement control. Genetic analyses have identified mutations in complement regulators that are associated with these diseases. Mutations have been identified in the fluid phase alternative pathway regulator Factor H and the membrane regulator Membrane Cofactor Protein MCP (CD46). The functional characterization of the mutant proteins allows to define the pathophysiological events on a molecular level. These new concepts and data on disease mechanisms allowed establishing new diagnostic and promising therapeutic approaches for several human kidney diseases. Molecular biology, clinics and therapy are discussed in this volume. 236 pp. Englisch.

Condition: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Role of genetic mutations in regulator proteinsNew therapies in human kidney diseasesProf. Zipfel is a well renowned scientist in this area of researchThe understanding how complement relates to glomerular diseaseshas evolved con.

Buch. Condition: Neu. Complement and Kidney Disease | Peter F Zipfel | Buch | Progress in Inflammation Research | xvi | Englisch | 2005 | Birkhäuser | EAN 9783764371661 | Verantwortliche Person für die EU: Springer Basel AG in Springer Science + Business Media, Heidelberger Platz 3, 14197 Berlin, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu Print on Demand.

Buch. Condition: Neu. This item is printed on demand - Print on Demand Titel. Neuware -It is evident that a defective or deregulated complement system results in kidney diseases. An important role of complement effector and regulatory proteins in pathological settings of the kidney has been demonstrated. A large panel of distinct human kidney diseases is caused by defective complement control. Genetic analyses have identified mutations in complement regulators that are associated with these diseases. Mutations have been identified in the fluid phase alternative pathway regulator Factor H and the membrane regulator Membrane Cofactor Protein MCP (CD46). The functional characterization of the mutant proteins allows to define the pathophysiological events on a molecular level. These new concepts and data on disease mechanisms allowed establishing new diagnostic and promising therapeutic approaches for several human kidney diseases. Molecular biology, clinics and therapy are discussed in this volume.Springer Nature c/o IBS, Benzstrasse 21, 48619 Heek 260 pp. Englisch.